Takeda will be investing approximately $30 billion into its U.S. operations over the next five years, the company announced.

Provides ReciBioPharm’s customers with access to NewBiologix’s Xcell-Eng-HEK293 celllines to develop and manufacture AAV ...

Gilead Sciences is investing an additional $11 billion into its U.S. operations, the company announced this week, bringing ...

ACG Packaging Materials’ greenhouse gas emission reduction targets have been validated by the Science Based Targets ...

How Praxis Packaging delivers flexible, reliable solutions for pharmaceutical contract packaging needs. As pressures on ...

Schreiner MediPharm’s new Digital Display Label allows trial sponsors to eliminate time-consuming manual relabeling.